As a new medication intended for quick pain relief nears a U.S. approval decision, critics worry about putting another strong opioid on the market amid a devastating opioid crisis.
Latest posts by Market Watch (see all)
- The Moneyist: Two sisters want to disinherit their half-sister after their father dies without a will - November 18, 2018
- What student-loan debt affects the rest of your life (it’s not pretty) - November 18, 2018
- Credit scores reveal red flags about a person that have nothing to do with money - November 18, 2018